The Cooper Companies, Inc. $COO Shares Purchased by Russell Investments Group Ltd.

Cooper Companies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Russell Investments Group increased its Cooper Companies stake by 292.4% in Q3, adding 413,067 shares to reach 554,352 shares valued at about $31.3 million. Institutional investors and hedge funds collectively own 24.39% of the company.
  • Company directors also bought shares, while analysts’ consensus remains “Hold”, with an average price target of $68.60. Recent target cuts included JPMorgan’s reduction to $58 and Citi’s to $60.
  • Cooper reported quarterly EPS of $1.15, beating estimates of $1.12, though revenue of $1.07 billion fell short of forecasts. The board also authorized a $3 billion share repurchase plan, covering up to 22.7% of shares.
  • MarketBeat previews top five stocks to own in December.

Russell Investments Group Ltd. grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 292.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 554,352 shares of the medical device company's stock after buying an additional 413,067 shares during the quarter. Russell Investments Group Ltd. owned 0.29% of Cooper Companies worth $31,338,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the business. Eurizon Capital SGR S.p.A. raised its holdings in shares of Cooper Companies by 57.8% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 382,178 shares of the medical device company's stock worth $21,605,000 after acquiring an additional 140,008 shares during the last quarter. CENTRAL TRUST Co boosted its stake in Cooper Companies by 879.0% during the 3rd quarter. CENTRAL TRUST Co now owns 3,583 shares of the medical device company's stock valued at $203,000 after purchasing an additional 3,217 shares during the last quarter. Fifth Third Bancorp boosted its stake in Cooper Companies by 0.8% during the 3rd quarter. Fifth Third Bancorp now owns 134,378 shares of the medical device company's stock valued at $7,596,000 after purchasing an additional 1,012 shares during the last quarter. Paradigm Asset Management Co. LLC acquired a new position in Cooper Companies during the 3rd quarter valued at about $73,000. Finally, New Mexico Educational Retirement Board increased its holdings in Cooper Companies by 98.3% during the 3rd quarter. New Mexico Educational Retirement Board now owns 19,238 shares of the medical device company's stock worth $1,088,000 after purchasing an additional 9,538 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Cooper Companies news, Director Paul A. Keel purchased 4,701 shares of the company's stock in a transaction that occurred on Friday, September 11th. The shares were acquired at an average cost of $53.18 per share, for a total transaction of $249,999.18. Following the completion of the acquisition, the director owned 4,701 shares of the company's stock, valued at $249,999.18. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Walter M. Rosebrough, Jr. purchased 7,000 shares of the company's stock in a transaction that occurred on Friday, September 11th. The shares were acquired at an average price of $54.11 per share, for a total transaction of $378,770.00. Following the completion of the acquisition, the director directly owned 17,000 shares of the company's stock, valued at $919,870. This trade represents a 70.00% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 34,701 shares of company stock valued at $1,880,039 over the last three months. Corporate insiders own 2.08% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on the company. JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $71.00 to $58.00 and set a "neutral" rating for the company in a research note on Thursday, September 10th. Citigroup reaffirmed a "neutral" rating and set a $60.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday, September 10th. Weiss Ratings cut Cooper Companies from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, October 28th. UBS Group decreased their price target on Cooper Companies from $75.00 to $66.00 and set a "neutral" rating for the company in a report on Thursday, September 10th. Finally, Barclays raised Cooper Companies to a "hold" rating in a research report on Wednesday, October 7th. Four research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Cooper Companies presently has a consensus rating of "Hold" and an average target price of $68.60.

Get Our Latest Research Report on Cooper Companies

Key Headlines Impacting Cooper Companies

Investors following COO have been watching these headlines:

Cooper Companies Stock Down 1.2%

Cooper Companies stock opened at $61.88 on Tuesday. The Cooper Companies, Inc. has a fifty-two week low of $51.01 and a fifty-two week high of $89.83. The stock has a market cap of $11.77 billion, a PE ratio of 21.12, a price-to-earnings-growth ratio of 2.44 and a beta of 0.83. The firm's 50-day simple moving average is $58.33 and its 200 day simple moving average is $68.06. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the firm posted $0.49 EPS. The firm's quarterly revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Research analysts predict that The Cooper Companies, Inc. will post 4.53 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, September 9th that allows the company to repurchase $3 billion in shares. This buyback authorization allows the medical device company to buy up to 22.7% of its stock through open market purchases. Share buyback plans are usually an indication that the company's board believes its shares are undervalued.

Cooper Companies Profile

(Free Report)

CooperCompanies is a global medical device company focused on vision care and women's health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women's health and fertility care.

Recommended Stories

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines